Chinese Bio-pharmaceutical Company TOT Biopharm Raises $102M Series B Round

Login to View

Suzhou-based bio-pharmaceutical company TOT Biopharm has raised US$102 million series B round led by Chinese local asset management 99Fund, according to the company’s announcement.

Continue reading with a China Money Network subscription

Join Now

Already have an account or paid subscription? Log in